Table 1.
db/db 14 days | wt 4 hr | |
---|---|---|
WWL113/control | WWL113/control | |
monoacylglycerols (MAG) | ||
C16:0 MAG | 0.6 | 0.8 |
C18:0 MAG | 0.4* | 1.5 |
C20:4 MAG | 0.7* | 0.5* |
diacylglycerols (DAG) | ||
C32:0 DAG | 0.7** | 0.9 |
C34:2 DAG | 0.4** | 0.8 |
C34:1 DAG | 0.2** | 0.9 |
C36:4 DAG (C16:0/C20:4 DAG) | 0.3** | 0.5** |
C38:5 DAG (C18:0/C20:4 DAG) | 0.6** | 0.6* |
triacylglycerols (TAG) | ||
C48:2 TAG | 0.4** | 1.0 |
C50:2 TAG | 0.4** | 1.2 |
C52:4 TAG | 0.7* | 1.7 |
C52:3 TAG | 0.7 | 1.2 |
C52:1 TAG | 0.6* | 1.1 |
C54:5 TAG | 0.6** | 1.0 |
C52:4 TAG | 0.5** | 0.9 |
C54:3 TAG | 0.5** | 0.9 |
C56:6 TAG | 0.7 | 0.9 |
lysophosphatidyl choline (LPC) | ||
C16:0 LPC | 0.9 | 1.2 |
phosphatidylcholine (PC) | ||
C34:1 PC | 0.8 | 1.2 |
C36:1 PC | 0.9 | 1.1 |
acyl carnitine | ||
C16:0 acylcarnitine | 1.2 | 0.9 |
p<0.05
p<0.01 with >1.4-fold or <0.7-fold of control